Detalhe da pesquisa
1.
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
Drug Saf
; 44(12): 1341-1353, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622421
2.
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials.
Hum Vaccin Immunother
; 17(7): 2050-2057, 2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33606577
3.
Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine.
Vaccine
; 38(18): 3489-3500, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818534